Received Nov 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 014F21A | IM / AR |
Reaction Summary: Within 24 hours of receiving the second Moderna COVID-19 vaccine dose, I began experiencing severe neurological symptoms. These escalated rapidly and persisted for months, leading to functional disability and ongoing neurological issues. Detailed Symptom Timeline (October?December 2021): October 13?14, 2021 (~24 hours after second dose) Severe weakness, near inability to walk Slurred, labored speech; difficulty forming words Vision disturbances: cloudy vision, trouble focusing, ?white-out? episodes lasting minutes Eyes did not improve with contact lenses or glasses Slowed processing and severe fatigue October 15?16, 2021 Cognitive dysfunction: forgot common names, typed and wrote inaccurately Mixed up words (e.g., ?[withheld]? instead of ?[withheld]?) without realizing Used a cane to walk due to instability Severe coordination issues Emergency Room visit due to suspected stroke; CT scan showed possible idiopathic intracranial hypertension Follow-up referral initiated for MRI and neurology October 18?28, 2021 Increasing hand tremors Intermittent vision loss and cloudy eyesight Difficulty focusing, speaking clearly, and processing basic thoughts Difficulty writing and typing (formerly typed 60+ WPM error-free) Inconsistent walking ability: some days with cane, some without Extreme fatigue and pressure sensation in head/ears Balance and driving became unsafe October 31?November 2021 Continued balance problems and near-falls (including two falls while on vacation) Daily headaches, brain fog, slurred speech, and "mental unplugging" Memory lapses for important dates and people Required assistance with paperwork and errands MRI completed: Report suggested small vessel disease and follow-up recommended November?December 2021 Persistent neurological deficits: leg weakness, speech issues, and cognitive dysfunction Ophthalmologist noted optic disc elevation consistent with pseudotumor cerebri Lumbar puncture performed 12/29/2021 ? revealed low CSF protein levels Urinary urgency/frequency and fatigue became daily issues Recurrent ?ice pick? headaches in left temple area Diagnosis of idiopathic intracranial hypertension strongly suspected by multiple providers Ongoing & Residual Effects (2022?Present) Persistent nerve pain, hand weakness, visual processing issues Cognitive issues and fatigue continue to interfere with work and daily life Continued monitoring for MS, IIH, and other autoimmune or neurodegenerative disorders Important Notes: I had no history of this level of neurological impairment prior to the second Moderna dose. The rapid onset, severity, and duration of these symptoms strongly correlate to vaccine timing. I have extensive medical documentation of these symptoms and test results (CT, MRI, LP, ophthalmology, PCP, and ER notes).
Some neurological issues - L'Hermittes Sign positive and reoccurring urticaria
Some neurological issues - L'Hermittes Sign positive and reoccurring urticaria
Losartan 50mg/day / Diazapam, 5 mg/3x/day
Sulfa Antibiotics, DTap Vaccine
October 16, 2021 CT/CTA of Head and Neck (ER Visit) Findings: No hemorrhage or stenosis. Possible idiopathic intracranial hypertension (IIH) suspected based on symptoms. October 28, 2021 Brain MRI Findings: Indicated cerebral small vessel disease; no mass or lesion reported. December 20, 2021 Ophthalmology Visit ? Findings: Elevated optic nerves, optic disc swelling. Diagnosis: Pseudotumor cerebri suspected. OCT recommended. December 29, 2021 Lumbar Puncture (Spinal Tap) Findings: Low CSF protein levels, opening pressure ok January?February 2022 Cervical/Thoracic Spine MRI (2/28/2022) Findings: Mild disc bulge at C6?7 Moderate facet arthropathy at multiple thoracic levels Mild canal stenosis at T10?11 Mild scoliosis Degenerative changes at T10 costotransverse joint
Both DTap vaccines as child, at 5 years old (unknown reaction) and again at 15 (Cellulitis infection, Injection area and surroun